Key Takeaways
- Guidance cut on macro headwinds: FY23 constant-currency growth outlook slashed to -2% to 0% and margin to 9%-9.5%, driven by a mortgage market collapse, a uniquely slow collections cycle, and healthcare deal delays.
- The mortgage-collections barbell broke the wrong way: Refinance volumes fell 86% YoY while the expected offset from collections failed to materialize because household balance sheets are the strongest in 40 years, delaying delinquencies.
- Non-mortgage strength is the silver lining: Organic revenue excluding mortgage grew 12.8% YoY CC, led by UK BFS (+11.9% YoY) and Healthcare (+21.2% YoY, +12.9% CC), proving the diversification thesis has traction.
- Management called out its own forecasting miss: The CEO acknowledged the forecast "muscle" needs strengthening after being caught off-guard by the speed of the mortgage decline and the slowness of the collections cycle, and noted the need for better forecasting and guidance.
- What to watch next quarter: Whether the mortgage bottom actually arrives (now pushed out by a quarter or two), whether collections delinquencies finally begin rising, and whether healthcare deal closures convert in Q4 as promised.
The Mortgage Shock & the Broken Hedge
- Mortgage degrew 7.7% YoY (10.2% CC): Aggressive Fed rate hikes crushed home sales, with refinance volumes down 86% YoY and purchase volumes down 42% YoY, and the origination portion of the acquired portfolio was severely impacted.
- The bottom keeps moving: Management had expected mortgage to bottom by Q3 FY23, but now believes increased headwinds will push that out by a quarter or two, with rate hikes expected to continue into CY2023.
- Servicing held up better but still declined QoQ: The mix has shifted to 35:65 origination-to-servicing, and while servicing is more resilient, absolute dollars fell sequentially.
- The acquisition underperformed: The Stonehill Group acquisition will miss its earn-out target due to adverse market conditions, though its quality control and due diligence services are finding some footing.
- Medium-term thesis intact: Total home sales are expected to be about 10% higher from 2024 onwards compared to the 2011-2020 annual average, and margin-pressured clients are evaluating transformation cost solutions that should drive outsourcing once volumes return.
Vipul Khanna: "Based on discussions with our clients and assessment of the market outlook, we were expecting that this business to bottom out by Q3 of this year, however taking the increased headwinds into account, we believe the bottom will now shift by a quarter or two."
Collections: The Hedge That Did Not Fire
- Delinquencies are rising slower than expected for this point in the cycle: Unemployment remains near 50-year lows and household cash balances are healthier than historically seen, making the path to collection volumes far more protracted than clients or the company expected.
- This caught everyone by surprise: Management explicitly stated that the unique strength of household balance sheets "has caught everybody by surprise including our clients," and this was a key reason non-mortgage guidance also had to come down.
- The pipeline is building but conversion is slow: Nine new clients were added in the quarter and the digital collection platform now enables onboarding every 6-8 weeks (down from 12-14 weeks), but new clients in Fintech and utilities have smaller ticket sizes and longer collection cycle build times.
- Legal collections face a lagged headwind: Lower placement volumes in CY2021 and CY2022 will create a drag on future revenue growth in this sub-segment.
- Clients are preparing for the turn: Top five US banks increased credit loss provisions 35% to 80% quarter-on-quarter in the September 2022 quarter, and client conversations are increasingly around capacity augmentation, signaling demand should materialize when delinquencies rise.
Vipul Khanna: "This time it is unique. The household balance sheet we have which cash balance with people is much healthier than what we have historically seen in the last whatever ex recession cycle is coming in and that has caught everybody by surprise including our clients in terms of how protracted the delinquencies and its impact on collection volume has been."
Healthcare: Strong Growth, Delayed Deals
- Healthcare grew 21.2% YoY (12.9% CC): Strength in Health Plans & Health Services (HPHS) more than offset lingering weakness in the provider business, and the company is now in 8 of the top 10 health plans.
- Deal closures slipped, not lost: Top-10 health plan RFPs and contract renewals are long, exhaustive exercises, and timelines extended beyond what was forecast for Q3/Q4 growth, pushing some revenue into next year. The company won a meaningful back-office deal with one of the top 10 health plans against top-three competitors.
- Provider business is waiting on the public health emergency to end: The segment plays in a niche of eligibility services and receivables management that is 100% onshore and very profitable, but automatic re-enrollment measures under the PHE (extended to mid-January) are suppressing normal volumes.
- Expanding into offshore-amenable mid-cycle RCM: The company is building capability in coding and AR follow-up, a new segment with a couple of irons in the fire, though it will take time to build.
- Medical redetermination is a coming tailwind: As the PHE ends, strong demand is expected from redetermination services, and the company has signed its first anchor clients for a digital solution in this area.
UK BFS & CMP: The Diversification Engines
- UK BFS grew 11.9% YoY despite political uncertainty and tough economic conditions, with demand, pipeline activity and physical adoption remaining strong. Two notable wins included an international payment Fintech and neobank Shawbrook.
- Fulfilment is the constraint, not demand: The UK is experiencing possibly the toughest labor market witnessed with unemployment near 50-year lows, putting pressure on onshore contact-center fulfilment and extending ramp timelines.
- Offshore shift accelerating: Key UK clients are realizing the tough market conditions and driving more offshore growth, which should ease fulfilment pressure over time.
- CMP grew 7.4% YoY (14.2% CC): Steady growth from the top client across products and service lines, plus increased offshoring interest given the onshore talent situation. Marquee wins were secured in digital media and edtech.
- Tech segment is small but has only upside: The CMT/tech segment is lower than expected and reflects market competitiveness, but management expects it to become a decent growth driver in the short to medium term, with good milestone wins expected in Q3.
Margins & the Path Back
- Operating margin fell 411 bps YoY to 8.4%: The decline was driven by headwinds from mortgage, the collections market situation, and healthcare deal delays, partially offset by cost actions.
- FY23 margin guidance cut to 9%-9.5%: The revision factors in additional pressure on mortgage, the unique collections situation, and healthcare deal delays.
- Normalized margins expected by Q4: Management expects to achieve a normalized operating margin by the fourth quarter, with Q4 traditionally strong for collections due to tax refunds and healthcare expected back on a growth trajectory.
- Portfolio rebalancing will help structurally: The mortgage portfolio will reduce significantly going into next year, while collections should be in a different place, and growth investments in adjacent areas should start to line up.
- Other income provided a one-time PAT boost: A gain of ₹57.86 crore was recognized relating to fair value of liabilities for variable consideration on FY22 acquisitions, expected to be settled in Q3 and Q4.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | -2% to 0% constant currency | FY2023 |
| Operating margin | 9% to 9.5% | FY2023 |
| Mortgage business bottom | Bottom expected to arrive, shifted from prior Q3 FY23 expectation | Shifted by a quarter or two from Q3 FY23 |
| Normalized operating margin | Achieve normalized margin level | Q4 FY23 |
| Healthcare (HPHS) growth | Moderation in Q3, then reasonable growth | Q3 and Q4 FY23 |
| Provider business volumes | Normal volumes return once public health emergency measures end | After PHE ends (extended to mid-January 2023) |
| Collections delinquencies | Delinquencies expected to rise | Over the coming quarters |
| Tech segment | Expected to become a decent growth driver | Short to medium term, going into next year |
| Mortgage portfolio weight | Reduced significantly | Going into next year |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Revenue | ₹1,488.2 crore ($187 million), +4.2% YoY in rupee terms and +1.8% YoY in constant currency |
| Organic revenue growth (excl. mortgage decline) | +12.8% YoY in constant currency |
| Operating margin | 8.4% (₹125.4 crore), decline of 411 bps YoY |
| Profit after tax | ₹129.4 crore (8.7% of revenue), PAT margin decline of 76 bps YoY |
| EPS | ₹1.84, degrew 6.1% YoY |
| Full-year revenue growth guidance (constant currency) | -2% to 0% |
| Full-year operating margin guidance | 9% to 9.5% |
| BFS vertical growth (constant currency) | -10.2% YoY |
| Mortgage business expected full-year degrowth | ~55%, implying headwinds of almost 50% to overall business |
| Healthcare segment growth (constant currency) | +12.9% YoY |
| CMT segment growth (constant currency) | +14.2% YoY |
| UK BFS growth | +11.9% YoY |
| Collections business combined quarterly run rate | $31 million to $32 million, vs ~$14.5 million organic in same quarter last year |
| Net debt | ₹605.5 crore ($74.4 million), reduction of ₹127.8 crore QoQ |
| DSO | 56 days, vs 59 days last quarter |
| Onshore voluntary attrition | ~50%, improved by 5 percentage points QoQ |